CAA Use Tied to Higher Arthroplasty Risk - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

CAA Use Tied to Higher Arthroplasty Risk

In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.

  • By

  • Andrea Surnit

  • June 1, 2026

  • 6 min

Share

Clinical Scorecard: CAA Use Tied to Higher Arthroplasty Risk

At a Glance

CategoryDetail
ConditionKnee or hip osteoarthritis
Key MechanismsCentrally acting analgesics vs. selective serotonin reuptake inhibitors
Target PopulationPatients aged 40 to 89 years with knee or hip osteoarthritis
Care SettingPrimary care settings

Key Highlights

  • Centrally acting analgesics associated with 81% higher hazard of knee or hip replacement compared to SSRIs.
  • Study used a population-based cohort design with propensity score matching.
  • Caution advised due to potential residual confounding by indication.

Guideline-Based Recommendations

Diagnosis

  • Evaluate patients for knee or hip osteoarthritis based on clinical criteria.

Management

    Monitoring & Follow-up

    • Monitor for joint replacement outcomes in patients prescribed centrally acting analgesics.

    Risks

    • Increased risk of knee or hip replacement associated with centrally acting analgesics.

    Patient & Prescribing Data

    Patients with knee or hip osteoarthritis initiating treatment.

    Clinical Best Practices

      Related Resources & Content

      Original Source(s)

      CAA Use Tied to Higher Arthroplasty Risk

      • by Andrea Surnit

      • June 1, 2026

      Related Content

      FDA Expands Marstacimab Indication in Hemophilia A and B

      Phase 3 BASIS and BASIS KIDS data supported the expanded indication across pediatric and inhibitor-pretreated populations.

      Pressure point: blood flow restriction exercise and the pain paradox in musculoskeletal injury and persistent pain populations—a narrative review

      Transdermal NSAID Matches Oral Celecoxib After Knee Replacement

      Randomized trial finds a topical anti-inflammatory patch provided similar pain relief, function, and safety as oral therapy during the first 6 weeks after surgery.